# Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD

Study · id `cardio:ct-nct02363972` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02363972](<https://clinicaltrials.gov/study/NCT02363972>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02363972

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 103 participants.

## Technical summary

Registry record NCT02363972. Allocation not applicable; no masking; primary purpose treatment. Start 2015-02-10 (actual); primary completion 2016-06 (actual). Results posted on 2020-09-09.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 103 participants (enrolled count; ClinicalTrials.gov record NCT02363972, source copy `cardio:ctgov-nct02363972-2021-11-09`, retrieved 2026-10-26)
- Started: 2015-02-10 (actual) (ClinicalTrials.gov record NCT02363972, source copy `cardio:ctgov-nct02363972-2021-11-09`, retrieved 2026-10-26)
- Primary completion: 2016-06 (actual) (ClinicalTrials.gov record NCT02363972, source copy `cardio:ctgov-nct02363972-2021-11-09`, retrieved 2026-10-26)
- Completion: 2016-06 (actual) (ClinicalTrials.gov record NCT02363972, source copy `cardio:ctgov-nct02363972-2021-11-09`, retrieved 2026-10-26)
- Results first posted: 2020-09-09 (ClinicalTrials.gov record NCT02363972, source copy `cardio:ctgov-nct02363972-2021-11-09`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02363972, source copy `cardio:ctgov-nct02363972-2021-11-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02363972-2021-11-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD
- Condition: End Stage Renal Disease
- Condition: AV Fistula
- Condition: Fistula
- Condition: End Stage Kidney Disease
- Intervention (Device): Ellipsys Vascular Access Catheter
- Lead sponsor: Medtronic Endovascular
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Medtronic Endovascular (`cardio:org-medtronic-endovascular`)

## Provenance

Content hash: 5ebbb6e37dd25505f37e91344fdbfa473699afc3df8d38c7e4ae5de8ebbf1fc0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
